Dr Maggie Wang

Senior Research Fellow
Medicine: Westmead Clinical School


Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Cao, Q., Lu, J., Li, Q., Wang, C., Wang, X., Lee, V., Wang, C., Nguyen, H., Zheng, G., Zhao, Y., Alexander, S., Wang, Y., Harris, D. (2016). CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy. Journal of the American Society of Nephrology, 278(5), 1344-1360. [More Information]
  • O'Connor, K., Read, S., Wang, X., Schibeci, S., Eslam, M., Ong, A., Weltman, M., Douglas, M., Mazzola, A., Craxi, A., Stewart, G., Liddle, C., George, J., Ahlenstiel, G., Booth, D., et al (2016). IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection. Genes and Immunity, 17(6), 328-334. [More Information]
  • Nikesitch, N., Tao, C., Lai, K., Killingsworth, M., Bae, S., Wang, X., Harrison, S., Roberts, T., Ling, S. (2016). Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response. Blood Cancer Journal, 6(6), 1-3. [More Information]

2016

  • Cao, Q., Lu, J., Li, Q., Wang, C., Wang, X., Lee, V., Wang, C., Nguyen, H., Zheng, G., Zhao, Y., Alexander, S., Wang, Y., Harris, D. (2016). CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy. Journal of the American Society of Nephrology, 278(5), 1344-1360. [More Information]
  • O'Connor, K., Read, S., Wang, X., Schibeci, S., Eslam, M., Ong, A., Weltman, M., Douglas, M., Mazzola, A., Craxi, A., Stewart, G., Liddle, C., George, J., Ahlenstiel, G., Booth, D., et al (2016). IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection. Genes and Immunity, 17(6), 328-334. [More Information]
  • Nikesitch, N., Tao, C., Lai, K., Killingsworth, M., Bae, S., Wang, X., Harrison, S., Roberts, T., Ling, S. (2016). Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response. Blood Cancer Journal, 6(6), 1-3. [More Information]

To update your profile click here. For support on your academic profile contact .